red fish

red fish Tata Martino bids farewell to Inter Miami; Javier Mascherano expected to be next coachThe National Highway Traffic Safety Administration , a bureaucratic first step that could eventually open the floodgates for fully driverless cars. But there’s a twist: the agency wants self-driving car companies to cough up more data. The proposed rules were first announced last year as the , also known as AV STEP. This program would allow the agency to authorize the sale and commercialization of more vehicles without traditional controls, like pedals and steering wheels, without hitting the annual cap on the number of exemptions to safety requirements. NHTSA is promising “an exemption pathway that is tailored for ADS-equipped vehicles,” suggesting a less onerous, time-consuming process for the release of fully driverless vehicles. In exchange, the agency is requesting more data from the companies that operate driverless cars, arguing that greater transparency is needed to foster public trust in the technology. “AV STEP would provide a valuable national framework at a pivotal time in the development of [automated driving system] technology. Safe, transparent, and responsible development is critical for this technology to be trusted by the public and reach its full potential. This proposal lays the foundation for those goals and supports NHTSA’s safety mission,” NHTSA Chief Counsel Adam Raviv said in a press release. “We encourage everyone to comment on our proposed program. By kick-starting the rulemaking process, the Biden administration is giving a pretty big end-of-the-year holiday gift to the companies that have been laboring for decades on autonomous vehicle technology without any national regulatory framework to guide them. The federal government has largely taken a back seat to in regulating autonomous vehicles, leaving states to develop their own rulebooks for safe deployment. Legislation that would dramatically increase the number of AVs on the road has been , with lawmakers at odds over a range of issues, including safety, liability, and the right number of exemptions from federal motor vehicle safety standards. The Federal Motor Vehicle Safety Standards is the government’s official checklist for everything a car needs before it can be sold to customers, including steering wheels, pedals, and sideview mirrors. Driverless cars typically don’t need these controls, forcing companies to request exemptions to safety rules from the federal government before they can put their vehicles on the road. Safety regulators keep a tight grip on these exemptions But safety regulators keep a tight grip on these exemptions. There is a cap of 2,500 exemptions that each company is allowed to request. And to date, only one company, Nuro, has that aren’t large enough for human passengers. for its driverless Cruise vehicles before eventually giving up. (Earlier this month, GM said it would .) Whether AV STEP survives into the next Trump administration, though, is an open question. For one, the incoming president is reportedly looking to that requires companies operating vehicles with driver assist, as well as self-driving cars, to report crashes and injuries to the federal government. Scrapping the crash reporting rule would greatly benefit Tesla, which to date, has . And Tesla CEO Elon Musk is a close advisor and donor to Trump. The fact that NHTSA is choosing to highlight the “enhanced transparency” under AV STEP could lead some to conclude that this rule is dead on arrival. After all, Trump is currently trying to kill the only transparency rule currently on the books for self-driving cars. Still, Musk is also lobbying Trump to ease restrictions on fully autonomous vehicles in advance of Tesla’s plans to produce its own . So anything’s possible. Safety advocates are calling the notice of proposed rulemaking “premature” and unnecessary. In a statement, Advocates for Highway and Auto Safety President Cathy Chase notes that the proposal is oddly timed, coming after the auto industry said it was in new vehicles by 2029. “With the auto industry vociferously stating it is not feasible to comply with parts of the AEB rule with widely used braking technologies in five years, allowing far more complex technology to control more driving functionalities without meeting minimum safety standards is incongruous at best and potentially deadly at worst,” Chase said. /

By MICHELLE L. PRICE and ROB GILLIES NEW YORK (AP) — President-elect Donald Trump’s recent dinner with Canadian Prime Minister Justin Trudeau and his visit to Paris for the reopening of the Notre Dame Cathedral were not just exercises in policy and diplomacy. They were also prime trolling opportunities for Trump. Related Articles National Politics | Trump names Andrew Ferguson as head of Federal Trade Commission to replace Lina Khan National Politics | Biden issues veto threat on bill expanding federal judiciary as partisan split emerges National Politics | Trump lawyers and aide hit with 10 additional felony charges in Wisconsin over 2020 fake electors National Politics | After withdrawing as attorney general nominee, Matt Gaetz lands a talk show on OANN television National Politics | What will happen to Social Security under Trump’s tax plan? Throughout his first term in the White House and during his campaign to return, Trump has spun out countless provocative, antagonizing and mocking statements. There were his belittling nicknames for political opponents, his impressions of other political figures and the plentiful memes he shared on social media. Now that’s he’s preparing to return to the Oval Office, Trump is back at it, and his trolling is attracting more attention — and eyerolls. On Sunday, Trump turned a photo of himself seated near a smiling first lady Jill Biden at the Notre Dame ceremony into a social media promo for his new perfume and cologne line, with the tag line, “A fragrance your enemies can’t resist!” The first lady’s office declined to comment. When Trudeau hastily flew to Florida to meet with Trump last month over the president-elect’s threat to impose a 25% tax on all Canadian products entering the U.S., the Republican tossed out the idea that Canada become the 51st U.S. state. The Canadians passed off the comment as a joke, but Trump has continued to play up the dig, including in a post Tuesday morning on his social media network referring to the prime minister as “Governor Justin Trudeau of the Great State of Canada.” After decades as an entertainer and tabloid fixture, Trump has a flair for the provocative that is aimed at attracting attention and, in his most recent incarnation as a politician, mobilizing fans. He has long relished poking at his opponents, both to demean and minimize them and to delight supporters who share his irreverent comments and posts widely online and cheer for them in person. Trump, to the joy of his fans, first publicly needled Canada on his social media network a week ago when he posted an AI-generated image that showed him standing on a mountain with a Canadian flag next to him and the caption “Oh Canada!” After his latest post, Canadian Immigration Minister Marc Miller said Tuesday: “It sounds like we’re living in a episode of South Park.” Trudeau said earlier this week that when it comes to Trump, “his approach will often be to challenge people, to destabilize a negotiating partner, to offer uncertainty and even sometimes a bit of chaos into the well established hallways of democracies and institutions and one of the most important things for us to do is not to freak out, not to panic.” Even Thanksgiving dinner isn’t a trolling-free zone for Trump’s adversaries. On Thanksgiving Day, Trump posted a movie clip from “National Lampoon’s Christmas Vacation” with President Joe Biden and other Democrats’ faces superimposed on the characters in a spoof of the turkey-carving scene. The video shows Trump appearing to explode out of the turkey in a swirl of purple sparks, with the former president stiffly dancing to one of his favorite songs, Village People’s “Y.M.C.A.” In his most recent presidential campaign, Trump mocked Florida Gov. Ron DeSantis, refusing to call his GOP primary opponent by his real name and instead dubbing him “Ron DeSanctimonious.” He added, for good measure, in a post on his Truth Social network: “I will never call Ron DeSanctimonious ‘Meatball’ Ron, as the Fake News is insisting I will.” As he campaigned against Biden, Trump taunted him in online posts and with comments and impressions at his rallies, deriding the president over his intellect, his walk, his golf game and even his beach body. After Vice President Kamala Harris took over Biden’s spot as the Democratic nominee, Trump repeatedly suggested she never worked at McDonalds while in college. Trump, true to form, turned his mocking into a spectacle by appearing at a Pennsylvania McDonalds in October, when he manned the fries station and held an impromptu news conference from the restaurant drive-thru. Trump’s team thinks people should get a sense of humor. “President Trump is a master at messaging and he’s always relatable to the average person, whereas many media members take themselves too seriously and have no concept of anything else other than suffering from Trump Derangement Syndrome,” said Steven Cheung, Trump’s communications director. “President Trump will Make America Great Again and we are getting back to a sense of optimism after a tumultuous four years.” Though both the Biden and Harris campaigns created and shared memes and launched other stunts to respond to Trump’s taunts, so far America’s neighbors to the north are not taking the bait. “I don’t think we should necessarily look on Truth Social for public policy,” Miller said. Gerald Butts, a former top adviser to Trudeau and a close friend, said Trump brought up the 51st state line to Trudeau repeatedly during Trump’s first term in office. “Oh God,” Butts said Tuesday, “At least a half dozen times.” “This is who he is and what he does. He’s trying to destabilize everybody and make people anxious,” Butts said. “He’s trying to get people on the defensive and anxious and therefore willing to do things they wouldn’t otherwise entertain if they had their wits about them. I don’t know why anybody is surprised by it.” Gillies reported from Toronto. Associated Press writer Darlene Superville contributed to this report.Why Miami’s Pop-Tarts Bowl appearance is important even after missing College Football PlayoffReid's game-winner lifts South Florida past Wright State, 73-72 at Myrtle Beach Invitational

LAS VEGAS , Dec. 10, 2024 /PRNewswire/ -- The veterinary vaccines market is experiencing robust growth driven by factors such as the rising prevalence of zoonotic diseases, increasing concerns about antimicrobial resistance in animals, and a growing demand for safe and efficient food production. Additionally, the heightened emphasis on minimizing animal morbidity and mortality from preventable diseases through regular immunization is significantly contributing to the market's revenue expansion during the forecast period (2024–2030). DelveInsight's Veterinary Vaccines Market Insights report provides the current and forecast market analysis, individual leading veterinary vaccine companies' market shares, challenges, veterinary vaccines market drivers, barriers, trends, and key market veterinary vaccine companies in the market. Key Takeaways from the Veterinary Vaccines Market Report As per DelveInsight estimates, North America is anticipated to dominate the global veterinary vaccines market during the forecast period. In the type segment of the veterinary vaccines market, the viral vector category had a significant share in 2023. Notable veterinary vaccine companies such as Hester Biosciences Limited, Boehringer Ingelheim International GmbH, Zoetis Services LLC, Elanco, Merck & Co., Inc., Indian Immunologicals Ltd., Phibro Animal Health Corporation, Biogénesis Bagó®, HIPRA, ARKO, Kyoto Biken Laboratories, Inc., Vaxxinova® International BV, Dyntec s. r. o., Brilliant Bio Pharma, BioTestLab, Virbac, KBNP, BIMEDA, Shchelkovo biocombinat, VAKSINDO ANIMAL HEALTH PVT. LTD, and several others, are currently operating in the veterinary vaccines market. In September 2022 , Boehringer Ingelheim launched Fencovis® which is the first vaccine against calf disease. In June 2022 , India's first homegrown COVID-19 vaccine Anocovax for animals, produced by the ICAR-National Research Centre on Equines (NRCE) was launched in India . In April 2022 , Ceva Animal Health launched the IBird vaccine against Infectious Bronchitis in India . To read more about the latest highlights related to the veterinary vaccines market, get a snapshot of the key highlights entailed in the Global Veterinary Vaccines Market Report Veterinary Vaccines Overview Veterinary vaccines are a cornerstone of animal healthcare, pivotal in preventing and controlling infectious diseases in domestic and wild animals. These vaccines bolster the immune system of animals, enabling them to combat pathogens effectively and reducing the spread of diseases. By protecting livestock, poultry, and pets, veterinary vaccines safeguard animal health, promote agricultural productivity, and ensure food security. They are also vital in managing zoonotic diseases, which can be transmitted from animals to humans, thus contributing to public health. Examples include vaccines for rabies, foot-and-mouth disease, and avian influenza, which protect animal populations and reduce the risk of epidemics. Advancements in biotechnology have significantly improved the efficacy and safety of veterinary vaccines. Innovations such as recombinant DNA technology, subunit vaccines, and mRNA-based approaches have led to the development of more targeted and effective immunizations with minimal side effects. Moreover, the use of adjuvants and delivery systems like nanocarriers has enhanced vaccine stability and immunogenicity. As the global demand for sustainable and ethical animal farming grows, the focus on vaccines as a preventive measure over antibiotics is increasing, aligning with the goals of One Health initiatives. These efforts emphasize the interconnectedness of human, animal, and environmental health, underscoring the critical role of veterinary vaccines in fostering a healthier world. Veterinary Vaccines Market Insights North America is projected to dominate the global veterinary vaccines market, driven by its robust infrastructure, advanced research capabilities, and widespread adoption of preventive veterinary healthcare practices. The region boasts a well-established veterinary healthcare system, including a high number of veterinary clinics and hospitals equipped with state-of-the-art facilities. Additionally, the presence of leading vaccine manufacturers, such as Zoetis and Merck Animal Health, fosters continuous innovation and availability of effective vaccines. Factors such as a growing pet population, increasing awareness of zoonotic diseases, and rising expenditure on pet healthcare further contribute to North America's leadership in this sector. The regulatory environment in the region also facilitates the rapid approval and distribution of vaccines, ensuring that animals, both livestock and companions, have timely access to preventive solutions. Furthermore, the region's large livestock industry plays a crucial role in driving demand for veterinary vaccines to safeguard animal health and ensure food safety. The United States , as a significant player in the global meat and dairy trade, places considerable emphasis on maintaining the health of its animal herds. Vaccines against diseases such as bovine viral diarrhea, avian influenza, and porcine reproductive and respiratory syndrome are in high demand to prevent economic losses in the livestock sector. Canada's initiatives to improve animal health standards and prevent disease outbreaks further bolster the regional market. As awareness grows about the role of veterinary vaccines in preventing antibiotic resistance and improving overall animal welfare, North America is expected to maintain its dominance in the veterinary vaccines market. To know more about why North America is leading the market growth in the veterinary vaccines market, get a snapshot of the Veterinary Vaccines Market Outlook Veterinary Vaccines Market Dynamics The veterinary vaccines market plays a pivotal role in ensuring the health and productivity of animals, catering to both companion animals and livestock. With a growing emphasis on animal welfare, zoonotic disease prevention, and food safety , the demand for effective vaccines continues to rise. Additionally, the industry is driven by the need to mitigate the economic impact of livestock diseases , which can cause significant losses for farmers and the agriculture industry. Vaccines help reduce the reliance on antibiotics, aligning with global efforts to combat antimicrobial resistance. One of the major dynamics influencing the veterinary vaccines market is the increasing prevalence of zoonotic diseases , which can transfer from animals to humans. This has spurred investments in research and development for innovative vaccines. Advances in biotechnology , such as recombinant DNA technology and gene editing, have enabled the development of more effective and targeted vaccines. The advent of next-generation vaccines, including DNA and RNA-based solutions, offers a promising horizon for the industry, especially in addressing complex diseases. Market growth is also shaped by regulatory frameworks , which can vary significantly across regions. While stringent regulations ensure vaccine safety and efficacy, they can also pose challenges for new entrants and prolong time-to-market for innovative solutions. Additionally, the cost of vaccine development and distribution , particularly in developing economies, remains a significant barrier. However, government initiatives and collaborations with global organizations , such as the World Organisation for Animal Health (OIE), are facilitating vaccine access in underserved regions. The companion animal segment is experiencing notable growth, driven by the rising pet population and increasing awareness among pet owners about preventive healthcare. In parallel, the livestock segment continues to dominate, propelled by the growing global demand for meat, milk, and other animal-derived products . The focus on sustainable livestock farming and disease prevention further fuels the demand for vaccines, as farmers aim to enhance productivity while reducing environmental impacts. In conclusion, the veterinary vaccines market is characterized by rapid technological advancements, a growing focus on zoonotic disease control, and evolving consumer awareness. While challenges such as high development costs and regulatory hurdles persist, opportunities abound in the form of emerging markets, novel technologies, and increasing collaborations within the global health ecosystem. This dynamic landscape underscores the critical role of veterinary vaccines in ensuring animal and human health alike. Get a sneak peek at the veterinary vaccines market dynamics @ Veterinary Vaccines Market Dynamics Analysis Veterinary Vaccines Market Assessment Veterinary Vaccines Market Segmentation Veterinary Vaccines Market Segmentation By Type: Inactivated Veterinary Vaccines, Live-Attenuated Veterinary Vaccines, Subunit Veterinary Vaccines, Recombinant Veterinary Vaccines, and Viral Vector Veterinary Vaccines Veterinary Vaccines Market Segmentation By Indication: Viral, Bacterial, and Others Veterinary Vaccines Market Segmentation By Animal Group: Poultry, Livestock, Companion Animals, and Others Veterinary Vaccines Market Segmentation By End User: Veterinary Clinics and Others Veterinary Vaccines Market Segmentation By Geography : North America , Europe , Asia-Pacific , and Rest of World Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View Which MedTech key players in the veterinary vaccines market are set to emerge as the trendsetter explore @ Veterinary Vaccines Companies Table of Contents Interested in knowing the veterinary vaccines market by 2030? Click to get a snapshot of the Veterinary Vaccines Market Trends Related Reports Vaccines Market Vaccines Market Insights, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key vaccines companies, including GlaxoSmithKline, Bharat Biotech, AstraZeneca, Bavarian Nordic A/S, BioNTech, Sanofi, Merck & Co., Inc, Pfizer Inc, Moderna, Meiji Holdings Co., Ltd., EMERGENT, CSL Limited, Johnson & Johnson, VBI Vaccines Inc., Valneva SE., Novavax, CanSinoBIO, Biokangtai, Dynavax Technologies, Zhi Fei Biological , among others. Veterinary Diagnostic Imaging Market Veterinary Diagnostic Imaging Market Insights, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key veterinary diagnostic imaging companies, including Canon Medical Systems ANZ Pty Limited, Carestream Health., Epica Animal Health, ESAOTE SPA, FUJIFILM Holdings America Corporation, Hallmarq Veterinary Imaging, IDEXX Laboratories Inc., IMV., General Electric Company, Mindray Group, Heska Corporation, Siemens Healthcare Limited, Konica Minolta Inc., E.I. Medical Imaging., Sedecal, DRAMIŃSKI S. A., Clear Ray Imaging., SIUI, Sonoscape Medical Corp., Reproscan , among others. Animal Nutrition Market Animal Nutrition Market Insight, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key animal nutrition companies, including Nutreco, Alltech, Dow, Novozymes, Tata Chemicals Ltd., ADM, Adisseo Cargill, Incorporated, DuPont, Kemin Industries, Inc., Phibro Animal Health Corporation, Rossari Biotech Limited, Avitech Nutrition Pvt. Ltd., Aries Agro Limited, Advanced Enzymes, Glanbia plc., Zinpro Corp., NOVUS INTERNATIONAL, Biovet Private Ltd., Balchem Inc., among others. Animal Intestinal Health Market Animal Intestinal Health Market Insights, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key animal intestinal health companies, including Anco Animal Nutrition Competence GmbH, Elanco Animal Health Incorporated, Royal DSM, Evonik, Kemin Industries, Inc., Balchem Corp., Nutreco, Alltech, Tata Chemicals Ltd., Adisseo Cargill, Phibro Animal Health Corporation, Rossari Biotech Limited, Avitech Nutrition Pvt. Ltd., Aries Agro Limited, Advanced Enzymes, Glanbia plc., Zinpro Corp., NOVUS INTERNATIONAL, Balchem Inc., Novozymes , among others. About DelveInsight DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Contact Us Shruti Thakur [email protected] +14699457679 https://www.delveinsight.com/medical-devices Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg SOURCE DelveInsight Business Research, LLPNFL tells Bears that last-second blocked field goal by Packers was clean play: source